Investor Name	Invest Money	Lead Investor	Propotion

Announced Date	Round	Money Raised	Investors
Feb 27, 2012	Post-IPO Equity	$ 83.70M	Biolding Investment,Naxyris,etc.	Detail
Sep 28, 2010	Post-IPO Equity	$ 13.77M	TotalEnergies Ventures	Detail
Jun 7, 2020	Post-IPO Equity	$ 200M		Detail
Oct 12, 2006	Series A	$ 20M	Khosla Ventures,Kleiner Perkins,etc.	Detail
Feb 7, 2008	Series Unknown	$ 2.35M		Detail
Jun 11, 2013	Post-IPO Debt	$ 30M		Detail
Jan 17, 2018	Grant	$ 25M	National Institutes of Health	Detail
Jun 26, 2010	Series D	$ 133M	Cosan S.A.,Procter & Gamble Company,etc.	Detail
Jul 31, 2014	Post-IPO Debt	$ 10.85M		Detail
Aug 14, 2008	Series B	$ 21M	DAG Ventures,Khosla Ventures,etc.	Detail
Oct 14, 2015	Post-IPO Equity	$ 57.60M		Detail
Oct 6, 2016	Post-IPO Equity	$ 5M		Detail
Apr 9, 2021	Post-IPO Equity	$ 300M		Detail
May 23, 2014	Post-IPO Equity	$ 75M		Detail
Apr 22, 2014	Post-IPO Equity	$ 4M		Detail
Aug 24, 2018	Post-IPO Equity	$ 46M		Detail
Jul 29, 2015	Post-IPO Equity	$ 140.97M	Temasek Holdings,Total,etc.	Detail
Apr 30, 2019	Post-IPO Equity	$ 34M	Foris Ventures,John Doerr,etc.	Detail
Sep 19, 2007	Series B	$ 70M	DAG Ventures,Khosla Ventures,etc.	Detail
Oct 6, 2016	Post-IPO Debt	$ 25M		Detail
Oct 1, 2009	Series C	$ 41.75M	Khosla Ventures,Kleiner Perkins,etc.	Detail
Oct 28, 2011	Post-IPO Equity	$ 7M		Detail
Aug 3, 2017	Post-IPO Equity	$ 50M	DSM,Vivo Capital	Detail
Dec 1, 2009	Grant	$ 24.30M		Detail
Sep 28, 2010	IPO	$ 84.80M		Detail